Correlation Between Pluri and BioLineRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pluri and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pluri Inc and BioLineRx, you can compare the effects of market volatilities on Pluri and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and BioLineRx.

Diversification Opportunities for Pluri and BioLineRx

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pluri and BioLineRx is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Pluri i.e., Pluri and BioLineRx go up and down completely randomly.

Pair Corralation between Pluri and BioLineRx

Given the investment horizon of 90 days Pluri Inc is expected to generate 0.74 times more return on investment than BioLineRx. However, Pluri Inc is 1.34 times less risky than BioLineRx. It trades about -0.01 of its potential returns per unit of risk. BioLineRx is currently generating about -0.1 per unit of risk. If you would invest  648.00  in Pluri Inc on August 27, 2024 and sell it today you would lose (158.00) from holding Pluri Inc or give up 24.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pluri Inc  vs.  BioLineRx

 Performance 
       Timeline  
Pluri Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pluri and BioLineRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pluri and BioLineRx

The main advantage of trading using opposite Pluri and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.
The idea behind Pluri Inc and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon